Ketamine Recruiting Phase 2 Trials for Malignancies / Depression / Palliative Care Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03410446Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
NCT03102736Ketamine and Nitroprusside for Depression